Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization

Autor: Guardo AC, Gómez CE, Vicens Diaz de Brito Fernandez, Pich J, Arnaiz JA, Perdiguero B, García-Arriaza J, González N, Sorzano COS, Jiménez L, Jiménez JL, Muñoz-Fernández MÁ, Gatell JM, Alcamí J, Esteban M, López Bernaldo de Quirós JC, García F, Plana M, RISVAC02boost study

Publikováno v: PLoS One
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

We have previously shown that an HIV vaccine regimen including three doses of HIV-modified vaccinia virus Ankara vector expressing HIV-1 antigens from clade B (MVA-B) was safe and elicited moderate and durable (1 year) T-cell and antibody responses i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::57bfbaf1e6bd99b42aa6d7966ce2407a
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14292

Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences

Autor: Santos JR, Blanco JL, Masiá M, Gutiérrez F, Pérez-Elías MJ, Iribarren JA, Force L, Antela A, Knobel H, Salavert M, López Bernaldo De Quirós JC, Pino M, Paredes R, Clotet B

Publikováno v: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FISABIO. Repositorio Institucional de Producción Científica

Objectives: The objective of this study was to evaluate the incidence, prevalence and clinical consequences of virological failure (VF) to raltegravir-based regimens in Spain. Methods: A multicentre, retrospective, observational study was performed i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::60ea846f988e3402d628f83e67092669
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2456

Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain.

Autor: Izquierdo R; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.; CIBERINFEC, Carlos III Health Institute, Madrid, Spain., Suárez-García I; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Group, Department of Internal Medicine, Infanta Sofia University Hospital, Infanta Sofia University Hospital and Henares University Hospital Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), Madrid, Spain.; European University of Madrid, Madrid, Spain., Gómez-García T; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.; CIBERINFEC, Carlos III Health Institute, Madrid, Spain., Marco-Sánchez C; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain., Puente-Ferreiro J; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain., Moreno C; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.; CIBERINFEC, Carlos III Health Institute, Madrid, Spain., Diaz A; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.; CIBERINFEC, Carlos III Health Institute, Madrid, Spain., Cabello-Clotet N; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Unit, Internal Medicine Department, San Carlos Clinical Hospital, Health Research Institute of the San Carlos Clinical Hospital (IdISSC), Madrid, Spain.; Complutense University of Madrid, Madrid, Spain., Vinuesa D; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, San Cecilio Clinical University Hospital, Granada, Spain., Blanco JL; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, Clínic Barcelona hospital, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain., Melús E; Department of Infectious Diseases, San Pedro University Hospital, Logroño, Spain., Gómez-Ayerbe C; Infectious Diseases Unit, Virgen de la Victoria University Hospital, Malaga Biomedical Research Institute and Nanomedicine Platform (IBIMA Plataforma-BIONAND), Málaga, Spain., Olalla J; Internal Medicine Department, Costa del Sol University Hospital, Marbella, Spain., Riera M; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Infectious Diseases Unit, Internal Medicine Department, Son Espases University Hospital, Illes Balears Health Research Institute (IdISBa), Palma de Mallorca, Spain., Bernardino JI; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; HIV Unit, Internal Medicine, Department, Hospital La Paz-Carlos III, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain., de López Bernaldo de Quirós JC; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, Gregorio Marañón General University Hospital, Madrid, Spain., Moreno S; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.; Department of Infectious Diseases, University Hospital Ramón y Cajal, Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.; Department of Medicine, Alcalá University, Madrid, Spain., Jarrín I; National Centre for Epidemiology, Carlos III Health Institute, Madrid, Spain.; CIBERINFEC, Carlos III Health Institute, Madrid, Spain.

Publikováno v: HIV medicine [HIV Med] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.

SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid.

Autor: González Guembe M; Universidad Complutense de Madrid, Seneca Av. Madrid, Spain., Tisner Pensado Y; Universidad Complutense de Madrid, Seneca Av. Madrid, Spain., Tejerina Picado F; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Diez C; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Pérez Latorre L; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Fanciulli C; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Parras Vázquez F; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., López Bernaldo de Quirós JC; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Berenguer J; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Padilla Ortega B; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Machado M; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Valerio Minero M; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Muñoz Garcia P; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Bouza Santiago E; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Galar A; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Catalan P; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Alonso R; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Bellón JM; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain., Aldámiz-Echevarría Lois T; Microbiology and Infectious Diseases Department, Gregorio Marañón Hospital, Madrid, Spain.; Instituto Investigacion Biomedica, Gregorio Marañón Hospital, Madrid, Spain.

Publikováno v: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2022 May; Vol. 38 (5), pp. 394-398. Date of Electronic Publication: 2022 Jan 28.

Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain.

Autor: Chamorro-de-Vega E; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Rodriguez-Gonzalez CG; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Manrique-Rodríguez S; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Lobato-Matilla E; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., García-Moreno F; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Olmedo M; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Correa-Rocha R; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Laboratory of Immune-Regulation, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Valerio M; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Aldámiz-Echevarria T; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Machado M; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Sancho-Gonzalez M; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Intensive Care Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Lopez-Bernaldo-de-Quirós JC; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Ruiz-Briones P; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Romero-Jiménez R; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Sarobe-González C; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Gimenez-Manzorro A; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Collado-Borrell R; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Fernandez-Llamazares CM; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Revuelta-Herrero JL; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Somoza-Fernandez B; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Garcia-Sanchez S; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Taladriz-Sender I; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Bouza E; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; CIBERES, CIBER Enfermedades Respiratorias, Madrid, Spain.; Departamento De Medicina. Facultad De Medicina, Universidad Complutense De Madrid, Madrid, Spain., Herranz A; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain., Muñoz P; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.; CIBERES, CIBER Enfermedades Respiratorias, Madrid, Spain.; Departamento De Medicina. Facultad De Medicina, Universidad Complutense De Madrid, Madrid, Spain., Sanjurjo M; Pharmacy Department. Hospital General Universitario Gregorio Marañón, Madrid, Spain.; Instituto De Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

Publikováno v: Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2021 Feb; Vol. 14 (2), pp. 249-260. Date of Electronic Publication: 2021 Jan 26.